Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588067 · ClinicalTrials.gov registry record
Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease
A clinical trial of Peripheral Arterial Disease, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 271
- Enrollment target
- 2
- Study locations
NCT01588067 is a study of Peripheral Arterial Disease that has completed, run by Kaiser Permanente. The registered enrollment target is 271 participants, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01588067, a study of Peripheral Arterial Disease, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 271 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is designed to develop a clinical registry of Peripheral Arterial Disease (PAD) patients undergoing lower extremity revascularization to describe the population and assess comparative effectiveness of endovascular therapy versus surgery. In addition, this study will conduct a prospective cohort study of patients treated medically or undergoing lower extremity revascularization at the VA and Kaiser Colorado to compare changes in health status.
Conditions Studied
Study Locations (2)
Colorado
- VA Eastern Colorado Health Care System - Denver
- Kaiser Permanente Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01588067
The ClinicalTrials.gov registry entry for NCT01588067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 271 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (94% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01588067 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01588067 about?
NCT01588067 is a clinical study titled "Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease". This study is designed to develop a clinical registry of Peripheral Arterial Disease (PAD) patients undergoing lower extremity revascularization to describe the population and assess comparative effectiveness of endovascular therapy versus surgery. In addition, this study will conduct a prospective ...
What is the current status of trial NCT01588067?
This trial is currently completed. The enrollment target is 271 participants. The study started on 2011-05. Estimated completion is 2014-09.
What conditions does trial NCT01588067 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
Who is sponsoring clinical trial NCT01588067?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01588067 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.